Andere Kunden interessierten sich auch für
![Advanced Statistics in Regulatory Critical Clinical Initiatives]( "Advanced Statistics in Regulatory Critical Clinical Initiatives")
Advanced Statistics in Regulatory Critical Clinical Initiatives136,99 €![Statistics in Drug Research]( "Statistics in Drug Research")
Statistics in Drug Research356,99 €![Biopharmaceutical Sequential Statistical Applications]( "Biopharmaceutical Sequential Statistical Applications")
Biopharmaceutical Sequential Statistical Applications329,99 €![Fundamental Concepts for New Clinical Trialists]( "Fundamental Concepts for New Clinical Trialists")
Fundamental Concepts for New Clinical Trialists123,99 €![Pharmaceutical Experimental Design and Interpretation]( "Pharmaceutical Experimental Design and Interpretation")
Pharmaceutical Experimental Design and Interpretation241,99 €![Dose Optimization in Drug Development]( "Dose Optimization in Drug Development")
Dose Optimization in Drug Development263,99 €![Quality Control and Regulatory Aspects for Biologicals]( "Quality Control and Regulatory Aspects for Biologicals")
Quality Control and Regulatory Aspects for Biologicals130,99 €
Taking into account the regulatory and scientific developments that have occurred since its predecessor, this third edition presents a comprehensive summary of the ever-expanding literature and research in the field. It focuses on regulatory requirements, current scientific and practical issues, and the statistical methodology of designing and analyzing bioequivalence studies. It contains four new chapters, along with several new and updated sections. This edition includes guidelines issued by the FDA, EMEA, and WHO, addresses frequently asked questions, and explores the key topics of sample size determination, meta-analysis, and pharmacokinetics.